middle.news
Mach7 Technologies Strengthens Position with Solid Q3 FY25 Results and CEO Transition
6:25am on Monday 2nd of June, 2025 AEST
•
Healthcare Technology
Read Story
Mach7 Technologies Strengthens Position with Solid Q3 FY25 Results and CEO Transition
6:25am on Monday 2nd of June, 2025 AEST
Key Points
Contracted Annual Recurring Revenue (CARR) of A$30.8M as of 31 March 2025
Annual Recurring Revenue (ARR) run rate at A$24.4M, slight decrease due to customer shift
Positive operating cash flow of A$2.6M in Q3 and cash balance of A$24.9M with no debt
On-market share buy-back program commenced, acquiring 3.4M shares to date
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mach7 Technologies (ASX:M7T)
OPEN ARTICLE